Rodrigo Bravo
- Molecular Biology top 2%
- Immunology top 2%
- Oncology top 2%
- Cellular and Molecular Neuroscience top 2%
- Cancer Research top 2%
- Co-authors
- Heather Macdonald-BravoPatricia A. BlundellRainer FrankThomas HerdegenSérgio A. LiraRolf-Peter RyseckStephen K. DurhamJulio E. Celis
- Topics
- Virus-based gene therapy research (11 papers)Microtubule and mitosis dynamics (5 papers)Cancer-related Molecular Pathways (5 papers)
- Partner nations
- United StatesGermanyChile
In The Last Decade
Rodrigo Bravo
58 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 3.2k
- Immunology 1.4k
- Oncology 1.2k
- Cellular and Molecular Neuroscience 1.0k
- Cancer Research 853
Countries citing papers authored by Rodrigo Bravo
This map shows the geographic impact of Rodrigo Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Bravo more than expected).
Fields of papers citing papers by Rodrigo Bravo
This network shows the impact of papers produced by Rodrigo Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Bravo. The network helps show where Rodrigo Bravo may publish in the future.
Co-authorship network of co-authors of Rodrigo Bravo
This figure shows the co-authorship network connecting the top 25 collaborators of Rodrigo Bravo. A scholar is included among the top collaborators of Rodrigo Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodrigo Bravo. Rodrigo Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Permisos transables frente a la introducción de un combustible limpio: Estudio de caso para PM-10 y NOx en Santiago, Chile. | 8 |
| 2 | 30 | |
| 3 | 12 | |
| 4 | Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel familybreakdown → | 688 |
| 5 | 24 | |
| 6 | 103 | |
| 7 | 105 | |
| 8 | 36 | |
| 9 | 154 | |
| 10 | 182 | |
| 11 | 62 | |
| 12 | 309 | |
| 13 | 253 | |
| 14 | 57 | |
| 15 | Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes. | 4 |
| 16 | 6 | |
| 17 | 33 | |
| 18 | 23 | |
| 19 | 37 | |
| 20 | 16 |
About Rodrigo Bravo
Rodrigo Bravo is a scholar working on Cellular and Molecular Neuroscience, Genetics and Immunology and Allergy, having authored 60 papers that have together received 6.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Microtubule and mitosis dynamics (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (853 citations) and Cellular and Molecular Neuroscience (1.0k citations). Rodrigo Bravo has collaborated with scholars based in United States, Germany and Chile. Frequent co-authors include Heather Macdonald-Bravo, Patricia A. Blundell, Rainer Frank, Thomas Herdegen, Sérgio A. Lira, Rolf-Peter Ryseck, Stephen K. Durham, Julio E. Celis, D S Barton and M. Zimmermann. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.